Understanding PPARgamma signaling in melanoma brain metastasis
了解黑色素瘤脑转移中的 PPARgamma 信号传导
基本信息
- 批准号:9913138
- 负责人:
- 金额:$ 41.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-12-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistApoptosisArachidonic AcidsAstrocytesBindingBiological AssayBrainCancer PatientCellsCephalicCessation of lifeClinicClinicalCoculture TechniquesCoinComplexDataDisseminated Malignant NeoplasmDistalE-CadherinExperimental ModelsFatty AcidsFatty acid glycerol estersGene Expression ProfilingGenesGeneticGoalsGrowthIn VitroIncidenceIndividualInvadedKineticsLocationMalignant NeoplasmsMalignant neoplasm of brainMass Spectrum AnalysisMediator of activation proteinMelanoma CellMesenchymalMetastatic MelanomaMetastatic malignant neoplasm to brainModelingNeoplasm MetastasisNeurogliaNeuronsOleic AcidsOrganPPAR PathwayPPAR gammaPathway interactionsPatientsPeroxisome Proliferator-Activated ReceptorsPharmacologyPhenotypePlayPrimary NeoplasmProcessProductionRelapseReporterResearchResponse ElementsRoleSamplingSeedsSignal TransductionSiteSoilStainsStromal CellsSystemic TherapyTechniquesTestingTimeTransitional EpitheliumUnsaturated Fatty AcidsXenograft procedurealdehyde dehydrogenasesastrogliosisbasebrain cellcancer cellcancer recurrencecell motilitycell typedesigneffective therapyexperimental studyin vitro Modelin vivoinsightintravital microscopymelanomametastatic processmigrationmouse modelnovelpre-clinicalpromotersmall molecule inhibitorspatiotemporaltherapeutic targettherapy resistanttreatment strategy
项目摘要
Project Summary
Metastasis, the spread of cancer from primary tumor site to distal organs, is the cause of over 80% of deaths
from cancer. The brain is one of the common metastasis locations. Brain metastasis, which develops in the late
course of illness, has become a significant problem in clinic due to its rising incidence as a consequence of
prolonged survival and limited efficacy of existing systemic therapies. Metastasis is a multi-step process that
requires the complex interplay between cancer cells and the stromal cells, a process commonly referred to as
“seed and soil hypothesis” coined over a century ago. The ‘soil’, the microenvironment, not only decides the
outgrowth of metastatic cancer cells, but also contributes to therapy resistance. The ‘seed’, the invaded cancer
cells, directly modifies the surrounding brain stromal cells. Our long-term goal is to dissect the complex
interactions between cancer cells and brain stromal cells during metastasis.
We have developed novel in vivo and in vitro models to address the gaps in our understanding of brain
microenvironmental control of metastatic outgrowth. Our data implicate that astrocytes, the unique and most
abundant brain cells, activate PPAR signaling in brain metastatic melanoma cells. Through an integrative
approach using in vitro co-culture assays and in vivo brain metastatic mouse models, Aim 1 will delineate the
role of PPAR pathway in melanoma cells during brain metastasis. We will track the dynamic changes and effect
of PPAR signaling in melanoma cells throughout the whole brain metastatic process. Moreover, PPAR
antagonist will be used in our pre-clinical mouse models to test its potential to treat melanoma brain metastasis.
Aim 2 will address how astrocytes activate PPAR signaling in the invades melanoma cells. We hypothesize
that astrocytes serve as ‘donor’ of unsaturated fatty acids, natural agonist of PPAR, to the invaded melanoma
cells. The gained insights may enable us to mechanistically deconstruct melanoma brain metastasis and develop
new treatment strategies for patients with little clinical recourse.
项目摘要
转移,即癌症从原发肿瘤部位向远端器官的扩散,是超过80%的死亡的原因
从癌症。脑是常见的转移部位之一。脑转移,在晚期发展
由于其发病率的上升,疾病过程已成为临床上的一个重要问题,
生存期延长和现有全身治疗的疗效有限。转移是一个多步骤的过程,
需要癌细胞和基质细胞之间复杂的相互作用,这一过程通常被称为
“种子和土壤假说”是一个世纪前提出的。“土壤”,即微环境,不仅决定了
转移性癌细胞的生长,但也有助于治疗抗性。“种子”,入侵的癌症
细胞,直接改变周围的脑基质细胞。我们的长期目标是解剖
转移过程中癌细胞和脑基质细胞之间的相互作用。
我们已经开发了新的体内和体外模型,以解决我们对大脑理解的差距
转移性生长的微环境控制。我们的数据表明,星形胶质细胞,这种独特的,
丰富的脑细胞,激活脑转移性黑色素瘤细胞中的PPAR γ信号传导。通过综合
使用体外共培养试验和体内脑转移小鼠模型的方法,Aim 1将描述
脑转移过程中黑色素瘤细胞中过氧化物酶体增殖物激活受体β通路的作用我们将跟踪动态变化和效果
在整个脑转移过程中,黑色素瘤细胞中的PPAR γ信号转导。此外,
拮抗剂将用于我们的临床前小鼠模型中,以测试其治疗黑色素瘤脑转移的潜力。
目的2将阐明星形胶质细胞如何激活侵入黑色素瘤细胞的过氧化物酶体增殖物激活受体信号。我们假设
星形胶质细胞作为入侵黑色素瘤的不饱和脂肪酸(PPAR γ的天然激动剂)的“供体”
细胞所获得的见解可能使我们能够机械地解构黑色素瘤脑转移,
新的治疗策略,为患者几乎没有临床资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Qing Chen其他文献
Qing Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Qing Chen', 18)}}的其他基金
Understanding PPARgamma signaling in melanoma brain metastasis
了解黑色素瘤脑转移中的 PPARgamma 信号传导
- 批准号:
10062491 - 财政年份:2019
- 资助金额:
$ 41.61万 - 项目类别:
Understanding PPARgamma signaling in melanoma brain metastasis
了解黑色素瘤脑转移中的 PPARgamma 信号传导
- 批准号:
10307076 - 财政年份:2019
- 资助金额:
$ 41.61万 - 项目类别:
Understanding PPARgamma signaling in melanoma brain metastasis
了解黑色素瘤脑转移中的 PPARgamma 信号传导
- 批准号:
10534117 - 财政年份:2019
- 资助金额:
$ 41.61万 - 项目类别:
Role of natural autoantibodies in autoimmune disease
天然自身抗体在自身免疫性疾病中的作用
- 批准号:
6814821 - 财政年份:2004
- 资助金额:
$ 41.61万 - 项目类别:
Role of natural autoantibodies in autoimmune disease
天然自身抗体在自身免疫性疾病中的作用
- 批准号:
7250253 - 财政年份:2004
- 资助金额:
$ 41.61万 - 项目类别:
Role of natural autoantibodies in autoimmune disease
天然自身抗体在自身免疫性疾病中的作用
- 批准号:
7085338 - 财政年份:2004
- 资助金额:
$ 41.61万 - 项目类别:
Role of natural autoantibodies in autoimmune disease
天然自身抗体在自身免疫性疾病中的作用
- 批准号:
6913548 - 财政年份:2004
- 资助金额:
$ 41.61万 - 项目类别:
Role of natural autoantibodies in autoimmune disease
天然自身抗体在自身免疫性疾病中的作用
- 批准号:
7364100 - 财政年份:2004
- 资助金额:
$ 41.61万 - 项目类别:
Role of natural autoantibodies in autoimmune disease
天然自身抗体在自身免疫性疾病中的作用
- 批准号:
7477135 - 财政年份:2004
- 资助金额:
$ 41.61万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 41.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 41.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 41.61万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 41.61万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 41.61万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 41.61万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 41.61万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 41.61万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 41.61万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 41.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)